Confidentiality Agreement In Clinical Trials Template for Saudi Arabia

Generate a bespoke document

What is a Confidentiality Agreement In Clinical Trials?

This Confidentiality Agreement In Clinical Trials is essential for any clinical research conducted in Saudi Arabia, where strict regulatory compliance and data protection requirements must be observed. The document is designed to protect confidential information exchanged during clinical trials, including patient data, research methodologies, and trial results, while ensuring compliance with Saudi Food and Drug Authority (SFDA) regulations, the Law of Clinical Trials, and Saudi data protection laws. It is particularly relevant when multiple parties are involved in clinical research, requiring careful handling of sensitive medical information and intellectual property. The agreement addresses both traditional confidentiality concerns and modern data protection challenges, including electronic data handling and cross-border data transfers, all within the framework of Saudi Arabian law and Islamic principles.

Trusted by high-performance teams

Reviewed by

Swetha Meenal

Legal Engineer, GenieAI

Swetha Meenal profile photo

A lawyer, legal researcher and legal tech founder, Swetha has built AI products deployed inside Tier 1 firms and enterprises. She ensures GenieAI's alignment with the latest regulation and executes testing on the legal robustness of Genie output.

Reviewed by

Imad Mohammed Nazar

Legal Engineer, GenieAI

Imad Mohammed Nazar profile photo

A Skadden-trained M&A lawyer, Imad advised on cross-border transactions and contractual risk before moving into legal AI. He reviews GenieAI's output for compliance and enforceability across our 150+ supported jurisdictions, as well as facilitating external benchmarking.

Jurisdiction

Saudi Arabia

Publisher

GenieAI

Sector

Business

Cost

Free to use

Last updated

About the Confidentiality Agreement In Clinical Trials

A Confidentiality Agreement In Clinical Trials is a crucial legal document that protects sensitive information when conducting clinical research in Saudi Arabia. You need this agreement to ensure compliance with strict regulatory requirements while safeguarding patient data, research protocols, trial results, and intellectual property shared among multiple parties involved in clinical trials.

When do you need this document?

You require this agreement whenever conducting clinical research involving multiple stakeholders in Saudi Arabia. This includes situations where pharmaceutical companies collaborate with research institutions, when principal investigators work with contract research organizations (CROs), or when medical centers partner with universities for clinical studies. The agreement becomes essential when sharing patient data, research methodologies, interim results, or proprietary information with ethics committees, laboratory service providers, or data management companies. You also need this document when conducting multi-site trials across different Saudi healthcare facilities or when international sponsors work with local research institutions, ensuring all parties understand their confidentiality obligations under Saudi law.

Key legal considerations

Your agreement must clearly define what constitutes confidential information, including patient data, study protocols, research findings, and commercial information. You should establish specific obligations for data handling, storage, and transmission, particularly for electronic data systems and cross-border transfers. The document must address permitted uses of confidential information, ensuring they align with the clinical trial's legitimate purposes while prohibiting unauthorized disclosure or commercialization. You need to include provisions for data retention periods, secure destruction procedures, and breach notification requirements. The agreement should also specify remedies for confidentiality breaches, including injunctive relief and monetary damages, while considering the unique challenges of clinical trial data that may have significant commercial and scientific value.

Legal requirements in Saudi Arabia

Your confidentiality agreement must comply with the Law of Clinical Trials (Royal Decree No. M/49), which establishes fundamental requirements for protecting participant information and research data. You must ensure alignment with SFDA Clinical Trial Regulations, which mandate specific data handling and confidentiality protocols for all clinical research activities. The agreement must incorporate requirements from the Personal Data Protection Law (PDPL), particularly regarding consent mechanisms, data processing limitations, and individual rights related to personal medical information. You should also consider the Law of Healthcare Professions, which governs medical practitioners' obligations regarding patient confidentiality. Additionally, your agreement must respect Saudi Contract Law principles derived from Sharia Law, ensuring ethical compliance and proper contract formation. The document should address local requirements for Arabic language provisions, dispute resolution mechanisms that comply with Saudi legal procedures, and recognition of local regulatory authority oversight throughout the clinical trial process.

GOVERNING LAW

Applicable law

This Confidentiality Agreement In Clinical Trials is drafted to comply with Saudi Arabia law. Key legislation includes:

Genie's Security Promise

Genie is the safest place to draft. Here's how we prioritise your privacy and security.

Your data is private:

We do not train on your data; Genie's AI improves independently

All data stored on Genie is private to your organisation

Your documents are protected:

Your documents are protected by ultra-secure 256-bit encryption

We are ISO27001 certified, so your data is secure

Organizational security:

You retain IP ownership of your documents and their information

You have full control over your data and who gets to see it

Ready to agree with confidence?
See Genie in action.